J PEDERSEN-BJERGAARD, J ERSBOLL, HM … - Annals of internal medicine, 1985 - Am Coll Physicians Of 602 patients treated for non-Hodgkin's lymphomas, 9 developed overt acute
nonlymphocytic leukemia or preleukemia with refractory cytopenia and cytogenetic
abnormalities of the bone marrow. A Kaplan-Meier estimate of the cumulative ... Cited by 139 - Related articles - All 4 versions
- ►aacrjournals.org [PDF] MH Greene, RC Young, JM Merrill, VT DeVita - Cancer Research, 1983 - AACR We evaluated the occurrence of second cancers among 517 patients with
non-Hodgkin's lymphoma (NHL) treated at the National Cancer Institute. Nine
cases of acute nonlymphocytic leukemia (ANL) were observed compared to 0.08 ... Cited by 107 - Related articles - All 3 versions
GA Gomez, KK Aggarwal, T Han - CA A Cancer Journal for Clinicians - interscience.wiley.com In a prospective randomized study of treatment with radiation therapy (RT) or RT
+ chemotherapy (CT) for patients with non-Hodgkin's lymphoma Stages I-III, one
patient developed an acute malignant myeloproliferative syndrome (AMSS) and ... Cited by 39 - Related articles - All 3 versions
RS Lavey, NL Eby, LR Prosnitz - CA A Cancer Journal for Clinicians - interscience.wiley.com The risk of a second malignancy was determined for 999 patients given primary
treatment using chemotherapy only, radiation therapy only, or both for Hodgkin's
Disease or a non-Hodgkin's lymphoma at Duke University Medical Center ... Cited by 55 - Related articles - All 2 versions
MH GREENE, EL HARRIS, DM GERSHENSON, … - Annals of internal medicine, 1986 - Am Coll Physicians We have evaluated the relation between alkylating agents and leukemic disorders
in 3363 1-year survivors of ovarian cancer who were treated in five randomized
clinical trials and at two large medical centers. Overall, 28 patients ... Cited by 110 - Related articles - All 4 versions
MH Greene, JD Boice, BE Greer, JA Blessing … - New England Journal of Medicine, 1982 - content.nejm.org We evaluated the occurrence of acute nonlymphocytic leukemia (ANL) among 1399
women with ovarian cancer who were treated in five randomized clinical trials.
Of the 1399 women, 998 had been treated with alkylating agents, and among ... Cited by 173 - Related articles - All 2 versions
J Pedersen-Bjergaard, L Specht, S Olesen … - Lancet(British edition), 1987 - cat.inist.fr Risk of therapy-related leukaemia and preleukaemia after Hodgkin's disease. Relation
to age, cumulative dose of alkylating agents, and time from chemotherapy. ... Cited by 126 - Related articles - All 4 versions
J Cuzick, S Erskine, D Edelman, DA Galton - British journal of cancer, 1987 - pubmedcentral.nih.gov Twelve of 648 patients in the Medical Research Council's first two trials in
myelomatosis have developed myelodysplasia or acute leukaemia. This corresponds
to a 5-year actuarial prevalence of 3% and an 8-year prevalence of 10%. ... Cited by 53 - Related articles - All 5 versions
- ►oxfordjournals.org [PDF] LB Travis, RE Curtis, M Stovall, EJ … - JNCI Journal of the National Cancer Institute, 1994 - jnci.oxfordjournals.org Background: There have been few evaluations of the risk of acute nonlymphocytic
leukemia (ANLL) following therapy for non-Hodgkin's lymphoma (NHL). Further, the
relation- ship between cumulative dose of cytotoxic drug, radiation dose to ... Cited by 79 - Related articles - BL Direct - All 6 versions
JM Kaldor, NE Day, F Pettersson, EA Clarke, D … - New England Journal of Medicine, 1990 - content.nejm.org An international collaborative group of cancer registries and hospitals
identified 114 cases of leukemia following ovarian cancer. We investigated the
possible etiologic role of chemotherapy, radiotherapy, and other factors, ... Cited by 159 - Related articles - All 7 versions
